Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections

Clinical Microbiology and Infection

Volumn 17, Issue 3, 2011, Pages 409-417

  Hot, A ^a   Maunoury, C ^a   Poiree, S ^a   Lanternier, F ^a   Viard, J P ^a   Loulergue, P ^a   Coignard, H ^a   Bougnoux, M E ^a   Suarez, F ^a   Rubio, M T ^a   Mahlaoui, N ^a   Dupont, B ^a   Lecuit, M ^a,b   Faraggi, M ^a   Lortholary, O ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Aspergillosis; Hepatosplenic candidiasis

Indexed keywords

ALEMTUZUMAB; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; GAMMA INTERFERON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; STEROID; TACROLIMUS; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE PULMONARY COCCIDIOIDOMYCOSIS; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BLACK GRAINS EUMYCETOMA; CANCER CHEMOTHERAPY; CANDIDA KRUSEI; CANDIDIASIS; CHILD; CHRONIC DISSEMINATED CANDIDIASIS; CHRONIC GRANULOMATOUS DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COCCIDIOIDOMYCOSIS; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DIABETES MELLITUS; DRUG UPTAKE; FEMALE; GIANT CELL ARTERITIS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HAIRY CELL LEUKEMIA; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMOSIS; HODGKIN DISEASE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMMUNOCOMPROMISED PATIENT; INTERVERTEBRAL DISK DEGENERATION; INVASIVE ASPERGILLOSIS; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOMA; MALE; MYCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN TRANSPLANTATION; OSTEOARTHRITIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; SCEDOSPORIUM APIOSPERMUM; SOLID TUMOR; SYSTEMIC MYCOSIS; TESTIS CANCER; WHOLE BODY IMAGING; ZYGOMYCOSIS;

HISTOPLASMA CAPSULATUM VAR. CAPSULATUM; ISSATCHENKIA ORIENTALIS; PHOMOPSIS; PSEUDALLESCHERIA BOYDII;

EID: 79751480817     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03301.x     Document Type: Article

References (21)

1. Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol 2007; 139: 519-531.
2. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609-622.
3. Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 2002; 15: 465-484.
4. Caillot D, Couaillier JF, Bernard A et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253-259.
5. Greene RE, Schlamm HT, Oestmann JW et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis 2007; 44: 373-379.
6. Legrand F, Lecuit M, Dupont B et al. Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis 2008; 46: 696-702.
7. Kumar R, Basu S, Torigian D, Anand V, Zhuang H, Alavi A. Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Rev 2008; 21: 209-224.
8. Nakamoto Y, Eisbruch A, Achtyes ED et al. Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy. Gynecol Oncol 2002; 84: 289-295.
9. De Winter F, Vogelaers D, Gemmel F, Dierckx RA. Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases. Eur J Clin Microbiol Infect Dis 2002; 21: 247-257.
10. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
11. Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis 2005; 41: 521-526.
12. Maertens J, Theunissen K, Verhoef G et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005; 1: 1242-1250.
13. Mahfouz T, Miceli MH, Saghafifar F et al. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. J Clin Oncol 2005; 23: 7857-7863.
14. Bakheet SM, Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 1998; 28: 352-358.
15. Ho AY, Pagliuca A, Maisey MN, Mufti GJ. Positron emission scanning with 18-FDG in the diagnosis of deep fungal infections. Br J Haematol 1998; 101: 392-393.
16. Chamilos G, Macapinlac HA, Kontoyiannis DP. The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. Med Mycol 2008; 46: 23-29.
17. Igai H, Gotoh M, Yokomise H. Computed tomography (CT) and positron emission tomography with [18F]fluoro-2-deoxy-D-glucose (FDG-PET) images of pulmonary cryptococcosis mimicking lung cancer. Eur J Cardiothorac Surg 2006; 30: 837-839.
18. Bleeker-Rovers CP, Warris A, Drenth JP, Corstens FH, Oyen WJ, Kullberg BJ. Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Infect 2005; 11: 493-495.
19. Ichiya Y, Kuwabara Y, Sasaki M et al. FDG-PET in infectious lesions: the detection and assessment of lesion activity. Ann Nucl Med 1996; 10: 185-191.
20. Franzius C, Biermann M, Hulskamp G et al. Therapy monitoring in aspergillosis using F-18 FDG positron emission tomography. Clin Nucl Med 2001; 26: 232-233.
21. Huang B, Wai-Ming Law M, Khong P-L. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology 2009; 251: 166-174.